1,647 results match your criteria: "University of Vermont Medical Center[Affiliation]"
Res Pract Thromb Haemost
May 2024
Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA.
Dermatol Surg
January 2025
Dermatology Professionals, Inc., East Greenwich, Rhode Island.
Anesthesiology
September 2024
Department of Anesthesiology, University of Vermont Medical Center, Burlington, Vermont.
Telemed J E Health
November 2024
Larner College of Medicine at the University of Vermont and University of Vermont Medical Center, Burlington, Vermont, USA.
Although telehealth was a viable means of delivering psychiatric care even before the COVID-19 public health emergency, flexibilities at the federal and state levels during the pandemic prompted mass adoption in a short timeframe. Little is known about how psychiatrists plan to offer care going forward and to what degree services will be offered virtually, in-person, or in a hybrid format. We conducted a survey of American Psychiatric Association (APA) members regarding telepsychiatry practice and potential barriers.
View Article and Find Full Text PDFJ Soc Cardiovasc Angiogr Interv
July 2024
Division of Cardiology, University of Vermont Medical Center, Burlington, Vermont.
J Soc Cardiovasc Angiogr Interv
July 2024
Harvard Medical School, Boston, Massachusetts.
Background: The choice of transcatheter aortic valve replacement (TAVR) prosthesis is crucial in optimizing short- and long-term outcomes. The objective of this study was to conduct a meta-analysis comparing outcomes of third-generation balloon-expandable valves (BEV) vs self-expanding valves (SEV).
Methods: Electronic databases were searched from inception to June 2023 for studies comparing third-generation BEV vs SEV.
JACC Cardiovasc Imaging
August 2024
Department of Medicine, University of Udine, Udine, Italy; Cardiothoracic Department, University Hospital Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Pericardial diseases have gained renewed clinical interest, leading to a renaissance in the field. There have been many recent advances in pericardial diseases in both multimodality cardiac imaging of diagnoses, such as recurrent, transient constrictive and effusive-constrictive pericarditis, and targeted therapeutics, especially anti-interleukin (IL)-1 agents that affect the inflammasome as part of autoinflammatory pathophysiology. There remains a large educational gap for clinicians, leading to variability in evaluation and management of these patients.
View Article and Find Full Text PDFArch Pathol Lab Med
August 2024
The Department of Pathology, Microbiology & Immunology. Vanderbilt University, Nashville, Tennessee (Rauch).
Context.—: Laboratory testing practices for diagnosis of Clostridioides difficile infection (CDI) have evolved in response to published guidelines, availability of highly sensitive nucleic acid amplification tests (NAATs), perceived problems with the specificity of NAATs, and CDI reporting requirements.
Objective.
J Natl Compr Canc Netw
July 2024
Department of Dermatology, Oregon Health & Science University, Portland, OR.
Clin Pediatr (Phila)
July 2024
Department of Radiology, Valleywise Health Medical Center, Phoenix, AZ, USA.
In this study, we describe the role of ultrasound in diagnosing pediatric peritonsillar abscesses (PTAs). A retrospective chart review was conducted on 54 children aged 4 to 17 years who had an ultrasound performed for suspected PTA. Based on ultrasound imaging, the patients were classified into 2 groups: PTA-positive (8, 14.
View Article and Find Full Text PDFActa Anaesthesiol Scand
November 2024
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Cytometry B Clin Cytom
July 2024
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
The publication of Clinical and Laboratory Standards Institute's guideline H62 has provided the flow cytometry community with much-needed guidance on development and validation of flow cytometric assays (CLSI, 2021). It has also paved the way for additional exploration of certain topics requiring additional guidance. Flow cytometric analysis of rare matrices, or unique and/or less frequently encountered specimen types, is one such topic and is the focus of this manuscript.
View Article and Find Full Text PDFCJC Open
June 2024
Kiniksa Pharmaceuticals, Lexington, Massachusetts, USA.
Background: Rilonacept inhibits the interleukin-1 pathway, and extended treatment in patients with recurrent pericarditis (RP) reduced recurrence risk by 98% in the phase 3 trial, RHAPSODY long-term extension (LTE). Severe acute respiratory syndrome (SARS)-CoV-2 vaccination and/or infection may trigger pericarditis recurrence, and in clinical practice, it is unknown whether to continue rilonacept during SARS-CoV-2 infection. This post-hoc analysis of the RHAPSODY LTE aimed to inform rilonacept management in RP patients vaccinated against SARS-CoV-2 or who contract COVID-19.
View Article and Find Full Text PDFGenet Med
October 2024
Department of Pathology and Laboratory Medicine, Children's Mercy Hospital Kansas City, MO.
Semin Intervent Radiol
April 2024
Division of Interventional Radiology, Department of Radiology, University of Vermont Medical Center, Burlington, Vermont.
Abdom Radiol (NY)
August 2024
University of Vermont Medical Center, Burlington, USA.
Introduction: Pediatric head and neck (HN) trauma is an important contributor to pediatric morbidity, resulting in significant downstream consequences. Few studies provide epidemiological predictors of pediatric HN trauma on a national scale. The present study aims to identify risk factors of HN injury and mortality in the pediatric population.
View Article and Find Full Text PDFJ Stroke Cerebrovasc Dis
September 2024
Department of Neurology, Westchester Medical Center, Valhalla, NY, USA; Department of Neurosurgery, Westchester Medical Center, Valhalla, NY, USA. Electronic address:
J Am Coll Radiol
December 2024
Department of Radiology, Larner College of Medicine at the University of Vermont, Burlington, Vermont; ACR Delegate to the American Medical Association House of Delegates; Division Chief Ultrasound Imaging, Director of CM; Associate Program Director Diagnostic Radiology Residency. Electronic address: https://twitter.com/NaiimAli.
Dig Dis Sci
August 2024
Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave., Boston, MA, 02215, USA.
Pancreatology
September 2024
Division of Gastroenterology at the University of Vermont Medical Center, USA. Electronic address:
Background/objectives: Ambulatory thromboprophylaxis (AT) in patients with pancreatic adenocarcinoma (PAC) reduces venous thromboembolism (VTE) risk and is recommended for patients receiving systemic chemotherapy. We evaluated VTE rates, severity, timing, and risk factors in PAC patients as well as AT rates and initiation times.
Methods: Patients diagnosed with PAC were included.
Res Pract Thromb Haemost
May 2024
Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Background: Multiple guidelines recommend assessment of bleeding and venous thromboembolism (VTE) risk in adult medical inpatients to inform prevention strategies. There is no agreed-upon method for VTE and bleeding risk assessment.
Objectives: To validate the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) VTE and bleeding risk scores in an independent population.
J Clin Microbiol
July 2024
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Crit Rev Eukaryot Gene Expr
June 2024
Department of Biochemistry, University of Vermont Larner College of Medicine, Burlington, VT 05405; University of Vermont Cancer Center, University of Vermont Larner College of Medicine, Burlington, VT 05405.
Objective criteria are required for prostate cancer (PCa) risk assessment, treatment decisions, evaluation of therapy, and initial indications of recurrence. Circulating microRNAs were utilized as biomarkers to distinguish PCa patients from cancer-free subjects or those encountering benign prostate hyperplasia. A panel of 60 microRNAs was developed with established roles in PCa initiation, progression, metastasis, and recurrence.
View Article and Find Full Text PDF